Earnings Call · Q3 FY2022·2022-11-10

Q3 22EPS +53.26%·Rev n/aQ2 22EPS +50.00%·Rev n/aQ1 22EPS +25.00%·Rev n/aQ4 21EPS n/a·Rev n/a⚠ consensus missing

Iterum Therapeutics plc ITRMF

Louise Barrett — Senior Vice President of Legal Affairs

Corey Fishman — Chief Executive Officer

Judy Matthews — Chief Financial Officer

+0.4%1d on move date−5.1% vs SPY3d+3.2%5d+0.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ITRMF calls or request research access.

More ITRMF calls Browse calls Request research access